RepliCel Life Sciences Inc.
REPCFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$7000
P/E Ratio—
52W High$0.042835
52W Low$0.00001
RepliCel Life Sciences Inc.（REPCF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · REPCF · 截至 2026-06-15
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.35M | $0.35M | $0.35M | $0.35M | $0.35M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.00M | $0.35M | $0.35M | $0.35M | $0.35M |
| Gross Margin %(computed) | 0.00% | 100.00% | 99.58% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.11M | $0.53M | $0.62M | $1.15M |
| G&A Expenses | $0.00M | $0.60M | $1.21M | $1.13M | $1.51M |
| Total Operating Expenses | $0.12M | $0.71M | $1.74M | $1.75M | $2.65M |
| Operating Income | $0.24M | ($0.36M) | ($1.39M) | ($1.39M) | ($2.30M) |
| Operating Margin %(computed) | 67.29% | -101.77% | -391.82% | -393.80% | -649.64% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.04M | $0.11M | $0.15M | $0.01M | $0.01M |
| Income Before Tax | ($0.25M) | ($0.10M) | ($0.31M) | ($0.74M) | ($4.07M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.40M) | ($0.10M) | ($0.31M) | ($0.74M) | ($4.07M) |
| Net Margin %(computed) | -113.63% | -27.50% | -88.20% | -210.04% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.13 |
| Wtd Avg Shares | 70.01M | 62.29M | 59.24M | 37.77M | 32.49M |
| EBITDA | $0.24M | ($0.36M) | ($1.39M) | ($0.74M) | ($4.07M) |
| EBITDA Margin %(computed) | 67.29% | -101.62% | -391.54% | -208.07% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · CAD · M
深入了解RepliCel Life Sciences Inc.
关于RepliCel Life Sciences Inc.（REPCF）损益表
RepliCel Life Sciences Inc.（REPCF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，REPCF实现营收$0.00B，毛利润$0.00B（毛利率0.00%），净利润($0.00B)（净利率-113.63%）。
常见问题
REPCF · 4 问RepliCel Life Sciences Inc.（REPCF）2025财年营收为$0.00B，同比down0.1%。
REPCF revenueREPCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15